Publications by authors named "Mark Head"

Claim this Profile
S
Safety and effectiveness of indirect radiofrequency ablation (closure FAST) of incompetent great saphenous veins with Type I aneurysms: Long-term results radiofrequency ablation for saphenous aneurysms.
Miloš D Pavlović, Spiro S Schuller, Mark M Head, David Kaiser, Maruša Jerše

Phlebology· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renewed assessment of the risk of emergent advanced cell therapies to transmit neuroproteinopathies.
Paul A De Sousa, Diane Ritchie, Alison Green, Siddharthan Chandran, Richard Knight, Mark W Head

Acta Neuropathol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susceptibility of Human Prion Protein to Conversion by Chronic Wasting Disease Prions.
Marcelo A Barria, Adriana Libori, Gordon Mitchell, Mark W Head

Emerg Infect Dis· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid amplification of prions from variant Creutzfeldt-Jakob disease cerebrospinal fluid.
Marcelo A Barria, Andrew Lee, Alison Je Green, Richard Knight, Mark W Head

J Pathol Clin Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prion diseases.
James W Ironside, Diane L Ritchie, Mark W Head

Handb Clin Neurol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human stem cell-derived astrocytes replicate human prions in a genotype-dependent manner.
Zuzana Krejciova, James Alibhai, Chen Zhao, Robert Krencik, Nina M Rzechorzek, Mark W Head

J Exp Med· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amyloid-β accumulation in the CNS in human growth hormone recipients in the UK.
Diane L Ritchie, Peter Adlard, Alexander H Peden, Suzanne Lowrie, Margaret Le Grice, Mark W Head

Acta Neuropathol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic Patients.
Jean Y Douet, Caroline Lacroux, Naima Aron, Mark W Head, Séverine Lugan

Emerg Infect Dis· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UK Iatrogenic Creutzfeldt-Jakob disease: investigating human prion transmission across genotypic barriers using human tissue-based and molecular approaches.
Diane L Ritchie, Marcelo A Barria, Alexander H Peden, Helen M Yull, James Kirkpatrick, Mark W Head

Acta Neuropathol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relative Abundance of apoE and Aβ1-42 Associated with Abnormal Prion Protein Differs between Creutzfeldt-Jakob Disease Subtypes.
Roger A Moore, Young Pyo Choi, Mark W Head, James W Ironside, Robert Faris

J Proteome Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.
Roger A Moore, Mark W Head, James W Ironside, Diane L Ritchie, Gianluigi Zanusso

PLoS Pathog· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.
Roger A Moore, Mark W Head, James W Ironside, Diane L Ritchie, Gianluigi Zanusso

PLoS Pathog· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variant CJD. 18 years of research and surveillance.
Abigail B Diack, Mark W Head, Sandra McCutcheon, Aileen Boyle, Richard Knight

Prion· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological and biochemical investigation of a woman diagnosed with genetic Creutzfeldt-Jakob disease shortly after parturition.
Mark W Head, Helen M Yull, Klara Törö, Eva Keller, Csilla Rozsa

Neuropathol Appl Neurobiol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of variably protease-sensitive prionopathy treated with doxycyclin.
Hamid Assar, Raffi Topakian, Serge Weis, Jasmin Rahimi, Johannes Trenkler, Mark W Head

J Neurol Neurosurg Psychiatry· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the zoonotic potential of animal prion diseases: in vivo and in vitro approaches.
Marcelo A Barria, James W Ironside, Mark W Head

Prion· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes.
Young Pyo Choi, Mark W Head, James W Ironside, Suzette A Priola

Am J Pathol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prion protein protease sensitivity, stability and seeding activity in variably protease sensitive prionopathy brain tissue suggests molecular overlaps with sporadic Creutzfeldt-Jakob disease.
Alexander H Peden, Deep P Sarode, Carl R Mulholland, Marcelo A Barria, Diane L Ritchie, Mark W Head

Acta Neuropathol Commun· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotype-dependent molecular evolution of sheep bovine spongiform encephalopathy (BSE) prions in vitro affects their zoonotic potential.
Zuzana Krejciova, Marcelo A Barria, Michael Jones, James W Ironside, Martin Jeffrey, Mark W Head

J Biol Chem· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gerstmann-Straüssler-Scheinker disease: novel PRNP mutation and VGKC-complex antibodies.
Matthew Jones, Sola Odunsi, Daniel du Plessis, Angela Vincent, Matthew Bishop, Mark W Head

Neurology· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human tonsil-derived follicular dendritic-like cells are refractory to human prion infection in vitro and traffic disease-associated prion protein to lysosomes.
Zuzana Krejciova, Paul De Sousa, Jean Manson, James W Ironside, Mark W Head

Am J Pathol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular barriers to zoonotic transmission of prions.
Marcelo A Barria, Aru Balachandran, Masanori Morita, Tetsuyuki Kitamoto, Rona Barron, Mark W Head

Emerg Infect Dis· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity?
Gabor G Kovacs, Alexander Peden, Serge Weis, Romana Höftberger, Anna S Berghoff, Mark W Head

Acta Neuropathol Commun· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human prion diseases: molecular, cellular and population biology.
Mark W Head

Neuropathology· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variably protease-sensitive prionopathy in the UK: a retrospective review 1991-2008.
Mark W Head, Helen M Yull, Diane L Ritchie, Jan P Langeveld, Nicholas A Fletcher

Brain· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis